The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Finance

IBT’s phase III study shows a significant reduction in the secondary endpoint, all-cause mortality
Clinical & Manufacturing

IBT’s phase III study shows a significant reduction in the secondary endpoint, all-cause mortality

SEP 4, 2024
ZBiotics Raises $12M Series A to bring genetically engineered probiotic products to market
Biotics and Supplements

ZBiotics Raises $12M Series A to bring genetically engineered probiotic products to market

SEP 2, 2024
Transferring an LBP program from one CDMO to another
Finance

Transferring an LBP program from one CDMO to another

JUL 31, 2024
Ancilia Biosciences Announces Closing of $4.2 Million Financing
Finance

Ancilia Biosciences Announces Closing of $4.2 Million Financing

JUL 18, 2024
SNIPR Biome receives funding for the development of CRISPR-medicines to improve EED in pregnant women
Finance

SNIPR Biome receives funding for the development of CRISPR-medicines to improve EED in pregnant women

JUL 1, 2024
Seres Therapeutics Enters Into Memorandum Of Understanding For Vowst™ Asset Sale To Nestlé Health Science
Finance

Seres Therapeutics Enters Into Memorandum Of Understanding For Vowst™ Asset Sale To Nestlé Health Science

JUN 6, 2024
Lallemand Health Solutions: Pioneering Microbiome Innovations with Expert’Biome™ CDMO
Finance

Lallemand Health Solutions: Pioneering Microbiome Innovations with Expert’Biome™ CDMO

JUN 4, 2024
Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact
Finance

Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact

MAY 8, 2024
Lallemand Health Solutions and dsm-firmenich: New Partnership for Early-Life Synbiotic Solutions
Biotics and Supplements

Lallemand Health Solutions and dsm-firmenich: New Partnership for Early-Life Synbiotic Solutions

APR 24, 2024
SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients
Clinical & Manufacturing

SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients

APR 22, 2024
EnteroBiotix Completes £27m Financing Round & Initiates Phase 2 Study in Patients with IBS
Clinical & Manufacturing

EnteroBiotix Completes £27m Financing Round & Initiates Phase 2 Study in Patients with IBS

APR 4, 2024